Kinnevik and Human Capital led a $200m Series C funding round in Transcarent.

Kinnevik, a Swedish investment company, and Human Capital, a venture capital firm, led a $200m Series C funding round in Transcarent, a developer of consumer-directed health and care platform. Additional investors include Ally Bridge Group, Northwell Health, Intermountain Healthcare, Rush University Medical Center, General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund, Jove Equity Partners, Threshold Ventures, and GreatPoint Ventures. “For years, we’ve been anxiously waiting for more wide-ranging reform towards value in the healthcare industry and felt it has never been fully addressed – mostly because no one entity was willing to build a better end-to-end health and care experience from the ground up. We see Transcarent as the first company to address the challenge head on in a new and different way that is focused, first and foremost, on the consumer,” Christian Scherrer, Kinnevik Investment Manager.